ENDOLOGIX, INC. Inactive Instrument
Endologix, Inc.
Equities
ELGXQ
US29266S3040
Medical Equipment, Supplies & Distribution
Presenter SpeechK. Gong (Analysts)Okay. So good morning, everyone. My name is Allen Gong. I'm ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Endologix, Inc. develops, manufactures, markets and sells medical devices for the treatment of aortic disorders. The Company's products are designed for the minimally-invasive endovascular treatment of abdominal aortic aneurysms (AAA). Its AAA products are developed on one of two platforms: traditional minimally-invasive endovascular aneurysm repair (EVAR) or endovascular aneurysm sealing (EVAS), the Company's solution for sealing the aneurysm sac while maintaining blood flow. The Company's EVAR products include the AFX Endovascular AAA System (AFX System), the VELA Proximal Endograft (VELA) and the Ovation Abdominal Stent Graft System (Ovation System). The Company's EVAS product is the Nellix Endovascular Aneurysm Sealing System (the Nellix EVAS System).
| 1st Jan change | Capi. | |
|---|---|---|
| +12.01% | 128B | |
| -7.91% | 11.26B | |
| +6.26% | 9.28B | |
| +35.53% | 5.42B | |
| +8.68% | 3.45B | |
| -8.89% | 2.8B | |
| -10.68% | 2.1B | |
| -10.77% | 1.98B | |
| -26.31% | 1.71B |
